A Study of Inclisiran in Participants With Homozygous Familial Hypercholesterolemia (HoFH)
Clinical trial NCT03851705 · COMPLETED
Trial details
- NCT number
- NCT03851705
- Sponsor
- Novartis Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-06
- Primary completion
- 2020-03-02
- Enrollment
- 56
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.